Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4 is a type I transmembrane glycoprotein found primarily on the surface of helper T lymphocytes but also present on monocytes, macrophages, dendritic cells, B cells, granulocytes, and certain brain regions. It acts as a co-receptor alongside the T-cell receptor (TCR), specifically recognizing antigens presented by major histocompatibility complex class II molecules. Structurally, it consists of four extracellular immunoglobulin-like domains connected to a short stalk region that traverses the membrane and ends with a cytoplasmic tail capable of recruiting Lck tyrosine kinase. This recruitment is essential for initiating intracellular signaling cascades that drive lymphokine production and full activation/motility/adhesion responses in helper T-cells. Beyond its physiological role in adaptive immunity—where it orchestrates cellular responses against pathogens—CD4 serves as the principal high-affinity cellular entry receptor for human immunodeficiency virus type 1 (HIV), making it central both to normal immune function and pathogenesis in diseases such as AIDS. Therapeutically relevant drugs target this molecule either to modulate immune activity or prevent viral entry.
Monoclonal antibodies can block or modulate CD4 function or deplete CD4+ cells. Inhibition of HIV entry by blocking gp120 binding site on CD4. Modulation of immune responses via interference with coreceptor function.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell surface glycoprotein CD4 (CD4).